decisionhealth Newsletters, Part B News - 2023 Issue 5 (May)
You can bill 2-hour esketamine code with therapy, and with prolonged codes
Subscribe or sign in to view the full article.
Article Overview
This piece covers Medicare and local coverage guidance for Spravato (esketamine) billing in a psychiatric setting. It discusses the esketamine-specific G-codes, the role of psychotherapy, whether prolonged service coding may be reported, and whether the drug itself is billed separately. The article is relevant to behavioral health coders, psychiatric practices, and outpatient billing teams that work with FDA-approved treatments under coverage and documentation requirements.
Why This Topic Matters
Esketamine billing can involve multiple code families and documentation-sensitive timing requirements, so understanding what is bundled, what may be separately reported, and what coverage sources apply helps reduce claim errors and denials.
Article Sections
-
Question
Introduces the billing scenario involving esketamine administration in a psychiatric encounter and asks about related reporting options.
-
Answer
Summarizes the coverage context, the general scope of the treatment, and the types of coding guidance discussed in the article.
-
Resource
Lists the referenced coverage resource related to esketamine billing and coding guidance.
What You Will Learn
- How esketamine billing is framed in outpatient psychiatric care
- What kinds of coding topics are addressed alongside esketamine administration
- How coverage references and documentation considerations relate to this service
- Which general billing questions commonly arise for this treatment
Who Should Read This
- Psychiatric practices
- Behavioral health coders
- Medical billing staff
- Compliance auditors
- Revenue cycle teams
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com